Unmet weight loss targets in real-world clinical practice: weight management and perceptions in China

Front Endocrinol (Lausanne). 2024 Nov 7:15:1470394. doi: 10.3389/fendo.2024.1470394. eCollection 2024.

Abstract

Aims: To describe weight management and perceptions in China.

Materials and methods: Data were from the Adelphi Real World Obesity Disease Specific Programme™, a cross-sectional survey between April and July 2022 of physicians managing people with obesity or overweight (PwO) and PwO in real-world clinical practice in China. At data collection, eligible PwO were aged ≥18 years, under weight management and/or had a body mass index (BMI) ≥28 kg/m2.

Results: In total, 100 physicians and 801 PwO were enrolled. More than two thirds of PwO (70.7%; 531/751) were not diagnosed with obesity until a BMI ≥30 kg/m2. Most PwO (78%; 625/801) were on treatment for at least one obesity-related complication (ORC). Physicians commonly initiated weight loss discussions with PwO who already had an ORC (48.0%; 48/100). According to physicians and PwO, the mean target BMI was set at 25.8 kg/m2 and 24.3 kg/m2, and the mean target percentage weight loss was 19.6% and 23.7%, respectively. Over a median 6.4 months of weight management, the mean percentage weight loss was 4.1%. Few PwO achieved the weight loss target set by their physician (9.9%; 69/695) or themselves (2.0%; 14/696). Most physicians and PwO were unsatisfied with the current weight loss (92.3% [739/801] and 82.0% [650/793], respectively).

Conclusions: These findings suggest that earlier intervention may be needed to address obesity as a disease. Most physicians and PwO recognized the importance of normal weight, but few PwO achieved weight loss targets, which may suggest an unmet need for improved weight management.

Keywords: China; dietary intervention; obesity therapy; real-world evidence; weight control.

MeSH terms

  • Adult
  • Aged
  • Body Mass Index*
  • China / epidemiology
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Obesity* / therapy
  • Overweight* / therapy
  • Practice Patterns, Physicians'
  • Weight Loss*

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Data collection was undertaken by Adelphi Real World as part of an independent survey, entitled the Adelphi Real World Obesity DSP. Eli Lilly and Company did not influence the original survey through either contribution to the design of questionnaires or data collection. The analysis described here used data from the Adelphi Real World Obesity DSP. The DSP is a wholly owned Adelphi product. Eli Lilly and Company is one of multiple subscribers to the DSP. This analysis was funded by Eli Lilly and Company.